Metropolitan Life Insurance CO Akouos, Inc. Transaction History

Metropolitan Life Insurance CO

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$7.65 - $11.38 $52,517 - $78,123	-6,865 Closed	0 $0
Q3 2021 Jun 21, 2023	BUY	$9.93 - $13.59 $68,169 - $93,295	6,865 New	6,865 $79,000
Q3 2021 Mar 30, 2023	SELL	$9.93 - $13.59 $7,189 - $9,839	-724 Reduced 9.54%	6,865 $79,000
Q3 2021 Nov 15, 2021	BUY	$9.93 - $13.59 $68,169 - $93,295	6,865 New	6,865 $80,000
Q2 2021 Aug 16, 2021	SELL	$11.87 - $15.96 $94 - $127	-8 Closed	0 $0

Q1 2021 Jun 26, 2023	BUY	$13.87 - $21.04 $105,259 - $159,672	7,589 New	7,589 $105 Million
Q1 2021 Mar 30, 2023	BUY	$13.87 - $21.04 $41,679 - $63,225	3,005 Added 65.55%	7,589 $105,000
Q1 2021 May 14, 2021	SELL	$13.87 - $21.04 $63,469 - $96,279	-4,576 Reduced 99.83%	8 $105,000
Q4 2020 Jun 22, 2023	BUY	$17.03 - $22.45 $78,065 - $102,910	4,584 New	4,584 $90,000
Q3 2020 Jun 26, 2023	BUY	$19.3 - $26.92 $88,471 - $123,401	4,584 New	4,584 $104,000
Q3 2020 Mar 30, 2023	BUY	$19.3 - $26.92 $88,471 - $123,401	4,584 New	4,584 $104,000
Q3 2020 Nov 13, 2020	BUY	$19.3 - $26.92 $88,471 - $123,401	4,584 New	4,584 $105,000

Ticker AKUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,929,000
Description
Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.